换一批
换一批Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
作者：
Behnood,Bikdeli [1]
;
Azita H,Talasaz [2]
;
Farid,Rashidi [3]
;
Hooman,Bakhshandeh [4]
;
Farnaz,Rafiee [5]
;
Parisa,Rezaeifar [6]
;
Elahe,Baghizadeh [7]
;
Samira,Matin [7]
;
Sepehr,Jamalkhani [5]
;
Ouria,Tahamtan [7]
;
Babak,Sharif-Kashani [5]
;
Mohammad Taghi,Beigmohammadi [8]
;
Mohsen,Farrokhpour [5]
;
Seyed Hashem,Sezavar [9]
;
Pooya,Payandemehr [10]
;
Ali,Dabbagh [11]
;
Keivan Gohari,Moghadam [12]
;
Hossein,Khalili [13]
;
Mahdi,Yadollahzadeh [14]
;
Taghi,Riahi [15]
;
Atefeh,Abedini [16]
;
Somayeh,Lookzadeh [17]
;
Hamid,Rahmani [12]
;
Elnaz,Zoghi [18]
;
Keyhan,Mohammadi [19]
;
Pardis,Sadeghipour [19]
;
Homa,Abri [20]
;
Sanaz,Tabrizi [21]
;
Seyed Masoud,Mousavian [21]
;
Shaghayegh,Shahmirzaei [12]
;
Ahmad,Amin [12]
;
Bahram,Mohebbi [18]
;
Seyed Ehsan,Parhizgar [18]
;
Rasoul,Aliannejad [14]
;
Vahid,Eslami [7]
;
Alireza,Kashefizadeh [22]
;
Paul P,Dobesh [7]
;
Hessam,Kakavand [23]
;
Seyed Hossein,Hosseini [24]
;
Shadi,Shafaghi [25]
;
Samrand Fattah,Ghazi [26]
;
Atabak,Najafi [27]
;
David,Jimenez [21]
;
Aakriti,Gupta [21]
;
Mahesh V,Madhavan [10]
;
Sanjum S,Sethi [11]
;
Sahil A,Parikh [14]
;
Manuel,Monreal [28]
;
Naser,Hadavand [29]
;
Alireza,Hajighasemi [30]
;
Majid,Maleki [2]
;
Saeed,Sadeghian [3]
;
Gregory,Piazza [31]
;
Ajay J,Kirtane [3]
;
Benjamin W,Van Tassell [31]
;
Gregg W,Stone [3]
;
Gregory Y H,Lip [31]
;
Harlan M,Krumholz [3]
;
Samuel Z,Goldhaber [31]
;
Parham,Sadeghipour [32]
作者单位：
Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
[1]
Yale/YNHH Center for Outcomes Research and Evaluation, New Haven, Connecticut, United States.
[2]
Cardiovascular Research Foundation, New York, New York, United States.
[3]
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
[4]
Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
[5]
Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran.
[6]
Rajaie Cardiovascular Medical and Research Center, Iran university of Medical Sciences, Tehran, Iran.
[7]
Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
[8]
Tobacoo Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
[9]
Department of Cardiology, Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
[10]
Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
[11]
Department of Internal Medicine, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
[12]
Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
[13]
Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
[14]
Department of Anesthesiology, School of Medicine Anesthesiology Research Center, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
[15]
Department of Internal Medicine, School of Medicine, Shariati Hospital, Tehran, Iran.
[16]
Department of Pharmacotherapy, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
[17]
Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
[18]
Chronic Respiratory Disease Research Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
[19]
Department of Pharmacotherapy, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
[20]
School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
[21]
Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran.
[22]
Department of Pulmonary and Critical Care, School of Medicine, Shariati Hospital, Tehran, Iran.
[23]
Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran.
[24]
Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
[25]
Shahid Dr. Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
[26]
College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, United States.
[27]
Respiratory Department, Hospital Ramón y Cajal, Madrid, Spain.
[28]
Medicine Department, Universidad de Alcalá, Madrid, Spain.
[29]
CIBER Enfermedades Respiratorias, Madrid, Spain.
[30]
Division of Cardiology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States.
[31]
Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
[32]
Universidad Católica de Murcia, Murcia, Spain.
[33]
Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States.
[34]
Division of Cardiology, Department of Internal Medicine, Pauley Heart Center, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States.
[35]
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
[36]
Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
[37]
Aalborg University, Aalborg, Denmark.
[38]
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States.
[39]
Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut, United States.
[40]
主题词
老年人(Aged);抗凝药(Anticoagulants);队列研究(Cohort Studies);危重病人医疗(Critical Care);剂量效应关系, 药物(Dose-Response Relationship, Drug);依诺肝素(Enoxaparin);体外膜氧合作用(Extracorporeal Membrane Oxygenation);女(雌)性(Female);出血(Hemorrhage);人类(Humans);重症监护病房(Intensive Care Units);伊朗(Iran);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);疾病大流行(Pandemics);血栓形成(Thrombosis)
DOI
10.1055/a-1485-2372
PMID
33865239
发布时间
2022-12-07
- 浏览0
Thrombosis and haemostasis
Thrombosis and haemostasis
131-141页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
